CA2261564C - Parathyroid hormone analogues for the treatment of osteoporosis - Google Patents

Parathyroid hormone analogues for the treatment of osteoporosis Download PDF

Info

Publication number
CA2261564C
CA2261564C CA002261564A CA2261564A CA2261564C CA 2261564 C CA2261564 C CA 2261564C CA 002261564 A CA002261564 A CA 002261564A CA 2261564 A CA2261564 A CA 2261564A CA 2261564 C CA2261564 C CA 2261564C
Authority
CA
Canada
Prior art keywords
hpth
leu
seq
analogue
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002261564A
Other languages
English (en)
French (fr)
Other versions
CA2261564A1 (en
Inventor
Jean-Rene Barbier
Paul Morley
Witold Neugebauer
Virginia J. S. Ross
James F. Whitfield
Gordon E. Willick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Council of Canada
Original Assignee
National Research Council of Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/691,647 external-priority patent/US5955425A/en
Application filed by National Research Council of Canada filed Critical National Research Council of Canada
Priority to CA002599885A priority Critical patent/CA2599885A1/en
Publication of CA2261564A1 publication Critical patent/CA2261564A1/en
Application granted granted Critical
Publication of CA2261564C publication Critical patent/CA2261564C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement Of Radiation (AREA)
CA002261564A 1996-08-02 1997-08-01 Parathyroid hormone analogues for the treatment of osteoporosis Expired - Fee Related CA2261564C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002599885A CA2599885A1 (en) 1996-08-02 1997-08-01 Parathyroid hormone analogues for the treatment of osteoporosis

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/691,647 US5955425A (en) 1996-08-02 1996-08-02 Parathyroid hormone analogues for the treatment of osteoporosis
US08/691,647 1996-08-02
US4056097P 1997-03-14 1997-03-14
US60/040,560 1997-03-14
PCT/CA1997/000547 WO1998005683A1 (en) 1996-08-02 1997-08-01 Parathyroid hormone analogues for the treatment of osteoporosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002599885A Division CA2599885A1 (en) 1996-08-02 1997-08-01 Parathyroid hormone analogues for the treatment of osteoporosis

Publications (2)

Publication Number Publication Date
CA2261564A1 CA2261564A1 (en) 1998-02-12
CA2261564C true CA2261564C (en) 2007-10-30

Family

ID=26717175

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002261564A Expired - Fee Related CA2261564C (en) 1996-08-02 1997-08-01 Parathyroid hormone analogues for the treatment of osteoporosis

Country Status (24)

Country Link
EP (1) EP0915911B1 (enExample)
JP (3) JP4122061B2 (enExample)
KR (1) KR100500859B1 (enExample)
CN (1) CN1176947C (enExample)
AT (1) ATE253078T1 (enExample)
AU (1) AU723728B2 (enExample)
BG (1) BG103128A (enExample)
BR (1) BR9711002B1 (enExample)
CA (1) CA2261564C (enExample)
CZ (1) CZ34799A3 (enExample)
DE (1) DE69725850T2 (enExample)
DK (1) DK0915911T3 (enExample)
EE (1) EE9900039A (enExample)
ES (1) ES2207740T3 (enExample)
FI (1) FI990126A7 (enExample)
GE (1) GEP20033095B (enExample)
IS (1) IS4962A (enExample)
LV (1) LV12293B (enExample)
NZ (1) NZ333809A (enExample)
PT (1) PT915911E (enExample)
RU (1) RU2203286C2 (enExample)
SI (1) SI9720057A (enExample)
SK (1) SK287397B6 (enExample)
WO (1) WO1998005683A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1261281A (zh) * 1997-05-14 2000-07-26 罗纳·布朗克罗尔药制品有限公司 肽甲状旁腺激素类似物
JP4486256B2 (ja) 1998-10-22 2010-06-23 ザ・ジェネラル・ホスピタル・コーポレイション 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体
AU1633200A (en) 1998-11-25 2000-06-13 General Hospital Corporation, The Human parathyroid hormone modifications, preparation and use
WO2000040698A1 (en) 1998-12-31 2000-07-13 The General Hospital Corporation Pth receptor and screening assay utilizing the same
JP2003505514A (ja) * 1999-07-28 2003-02-12 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア 破骨細胞生成を阻害する方法
US6316410B1 (en) * 1999-09-22 2001-11-13 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
AU2002339843B2 (en) 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
JP4959917B2 (ja) * 2001-08-17 2012-06-27 ノバルティス アーゲー 副甲状腺ホルモンフラグメント用経口送達剤としての５−ｃｎａｃ
MXPA04006728A (es) 2002-01-10 2005-08-19 Osteotrophin Llc Tratamiento de desordenes oseos con medicamentos anabolicos esqueleticos.
EP1567178A4 (en) * 2002-11-01 2009-07-15 Amgen Inc MODULATORS OF RECEPTORS FOR NEUTRAL THERAPY HORMONE AND SIDE-HORSE HORMONE-RELATED PROTEINS
CN100508957C (zh) * 2003-01-21 2009-07-08 尤尼金实验室股份有限公司 肽经口输递的改进
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
WO2007130113A2 (en) * 2005-09-06 2007-11-15 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
EP2056862A2 (en) * 2006-07-31 2009-05-13 Zelos Therapeutics, Inc. Parathyroid hormone analogues and uses thereof
KR101108354B1 (ko) 2006-10-13 2012-01-25 일라이 릴리 앤드 캄파니 Ｐｔｈ 수용체 조절제로서의 페길화된 ｐｔｈ 및 그의 용도
CA2694667C (en) 2007-08-01 2018-10-30 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
RU2604809C2 (ru) * 2010-05-13 2016-12-10 Дзе Дженерал Хоспитал Корпорейшн Аналоги паратиреоидного гормона и их применение
CN105440126B (zh) * 2015-12-31 2019-10-25 南京工业大学 治疗骨质疏松的α-螺旋多肽及其制备方法与应用
WO2019018238A1 (en) 2017-07-15 2019-01-24 The Regents Of The University Of California CATHEPSIN K OSTEOADSORBENT FLUOROGEN SUBSTRATE FOR THE IMAGING OF OSTEOCLAST ACTIVITY AND MIGRATION
WO2020064190A1 (en) 2018-09-26 2020-04-02 Borealis Ag Propylene copolymer composition with excellent optical and mechanical properties
CN113549144A (zh) * 2021-06-30 2021-10-26 华南理工大学 一种特立帕肽hPTH(1-34)的生产和纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5317010A (en) * 1991-10-10 1994-05-31 Peter K. T. Pang Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis

Also Published As

Publication number Publication date
CN1231676A (zh) 1999-10-13
JP4122061B2 (ja) 2008-07-23
ATE253078T1 (de) 2003-11-15
SK13299A3 (en) 1999-10-08
KR20000029783A (ko) 2000-05-25
JP2007254480A (ja) 2007-10-04
SK287397B6 (sk) 2010-08-09
AU723728B2 (en) 2000-09-07
DE69725850T2 (de) 2004-08-19
SI9720057A (sl) 1999-12-31
FI990126A0 (fi) 1999-01-22
DE69725850D1 (de) 2003-12-04
AU3690597A (en) 1998-02-25
BR9711002A (pt) 2002-01-15
CZ34799A3 (cs) 1999-07-14
GEP20033095B (en) 2003-10-27
KR100500859B1 (ko) 2005-07-14
NZ333809A (en) 2000-07-28
CA2261564A1 (en) 1998-02-12
CN1176947C (zh) 2004-11-24
DK0915911T3 (da) 2004-03-08
BG103128A (bg) 2000-05-31
EP0915911A1 (en) 1999-05-19
LV12293B (en) 2000-11-20
JP2001500845A (ja) 2001-01-23
FI990126L (fi) 1999-03-31
FI990126A7 (fi) 1999-03-31
JP2009057386A (ja) 2009-03-19
PT915911E (pt) 2004-03-31
RU2203286C2 (ru) 2003-04-27
EE9900039A (et) 1999-08-16
LV12293A (lv) 1999-06-20
IS4962A (is) 1999-01-29
WO1998005683A1 (en) 1998-02-12
BR9711002B1 (pt) 2011-09-06
JP4224111B2 (ja) 2009-02-12
ES2207740T3 (es) 2004-06-01
EP0915911B1 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
US6110892A (en) Parathyroid hormone analogues for the treatment of osteoporosis
CA2261564C (en) Parathyroid hormone analogues for the treatment of osteoporosis
US6316410B1 (en) Parathyroid hormone analogues for the treatment of osteoporosis
US5955425A (en) Parathyroid hormone analogues for the treatment of osteoporosis
US7410948B2 (en) Analogs of parathyroid hormone
RU2198182C2 (ru) Аналоги гормона паращитовидной железы
US6544949B1 (en) Analogs of parathyroid hormone
CN101108878A (zh) 胰高血糖素样肽-1的类似物
US20090226477A1 (en) Pth2 receptor selective compounds
EP1352912A1 (en) Parathyroid hormone analogues for the treatment of osteoporosis
HK1059939A (en) Parathyroid hormone analogues for the treatment of osteoporosis
CA2599885A1 (en) Parathyroid hormone analogues for the treatment of osteoporosis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130801